Infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
AssigneePfizer Inc.
InventorsJay G. Calvert, Michael G. Sheppard, Siao-Kun W. Welch
Life of this patent
Estimating the term…
Loading patent…
AssigneePfizer Inc.
InventorsJay G. Calvert, Michael G. Sheppard, Siao-Kun W. Welch
Estimating the term…
The invention provides isolated polynucleotide molecules, including plasmids; viral vectors; and transfected host cells that comprise a DNA sequence encoding an infectious RNA sequence encoding a North American PRRS virus; and also North American PRRS viruses encoded thereby. The invention further provides isolated infectious RNA molecules encoding a North American PRRS virus. The invention also provides isolated polynucleotide molecules, infectious RNA molecules, viral vectors, and transfected host cells encoding genetically-modified North American PRRS viruses; and genetically-modified North American PRRS viruses encoded thereby. The invention also provides vaccines comprising such plasmids, RNA molecules, viral vectors, and North American PRRS viruses, and methods of using these vaccines in swine and in other animals. Also provided are isolated polynucleotide molecules, viral vectors, and transfected host cells that comprise a nucleotide sequence encoding a peptide of a North American PRRS virus. These viral vectors and transfected host cell lines are useful in providing peptides to compensate for mutated peptide coding sequences of DNA sequences encoding genetically-modified North American PRRS viruses so that functional virions can be generated.
A plasmid capable of directly transfecting a suitable host cell and expressing a Porcine Reproductive and Respiratory Syndrome (PRRS) virus from the suitable host cell so transfected, which plasmid comprises a) a DNA sequence encoding an infectious RNA molecule encoding the PRRS virus, and b) a promoter capable of transcribing said infectious RNA molecule in said suitable host cell.
An isolated polynucleocide molecule comprising a DNA sequence encoding an infectious RNA molecule encoding a North American PRRS virus that is genetically modified such that when it infects a porcine animal it is unable to produce PRRS in said animal, wherein said DNA sequence is SEQ ID NO:
A method for preparing a genetically modified PRRS virus that is capable of eliciting an immunoprotective response in a mammal or a bird vaccinated therewith, which method comprises obtaining an isolated DNA encoding an infectious RNA molecule which encodes a wild-type PRRS virus;
An isolated polynucleotide molecule comprising a nucleotide sequence that encodes a PRRS virus, wherein said nucleotide sequence is an RNA molecule corresponding to a DNA sequence that is SEQ ID NO:
An isolated polynucleotide molecule comprising a nucleotide sequence that encodes a PRRS virus, wherein said nucleotide sequence is an RNA molecule corresponding to a DNA sequence that is SEQ ID NO:
An isolated polynucleotide molecule comprising a nucleotide sequence that encodes a PRRS virus, wherein said nucleotide sequence is an RNA molecule corresponding to a DNA sequence that is SEQ ID NO:
Dependencies are inferred from the claim text.